BTIG Chief Market Technician Jonathan Krinsky thinks the market can “continue to make upside progress” into year-end and sees a new all-time high for the S&P 500 (SPX) above 6,100. However, volatility ...

SunCar Technology Group (NASDAQ:SDA) is on watch after BTIG Research initiated coverage on the cloud-based provider of digitalized automotive services and auto e-insurance solutions with a Buy rating.

BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating on the shares as ...

Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...

On Friday, FREYR Battery Inc (FREY) stock saw a modest uptick, ending the day at $3.03 which represents no change from the prior close of of $3.03. The stock opened at $2.95 and touched a low of $2.85 ...

Equities research analysts at BTIG Research assumed coverage on shares of SunCar Technology Group (NASDAQ:SDA – Get Free ...

On Friday, Plug Power Inc (PLUG) stock saw a modest uptick, ending the day at $2.38 which represents no change from the prior close of of $2.38. The stock opened at $2.36 and touched a low of $2.28 ...

According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...

BTIG raised the firm’s price target on Darden (DRI) to $205 from $195 and keeps a Buy rating on the shares after its Q2 ...

BTIG said it would be cautious on Apple's (NASDAQ:AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the market can continue to make upside progress into the year-end and see a ...

BTIG initiated coverage of Cartesian Therapeutics (RNAC) with a Buy rating and $42 price target Cartesian is pioneering the field of mRNA-based CART cell therapies for autoimmune disorders, the ...

BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...